[1] |
ZHANG Yu, PENG Ying, WANG Guangji, SUN Jianguo.
Advances in study of phase II metabolic enzyme expression and activity under diseases status
[J]. Chinese Journal of Clinical Pharmacology and Therapeutics, 2020, 25(6): 686-700.
|
[2] |
YANG Leixi, FENG Kai, FAN Xueting, WEI Yanchun, LIU Tingting, TANG Yiqun.
Novel compound HYY-002 inhibits paroxysmal atrial fibrillation in rats
[J]. Chinese Journal of Clinical Pharmacology and Therapeutics, 2019, 24(12): 1347-1352.
|
[3] |
XU Shengsong, TAO Hui, SHI Kaihu, DING Jifei.
Expression and clinical significance of EZH2 and α-SMA in myocardium of patients with rheumatic heart disease with atrial fibrillation
[J]. Chinese Journal of Clinical Pharmacology and Therapeutics, 2019, 24(12): 1371-1375.
|
[4] |
ZHANG Yiwen, LOU Qianwen, ZHONG Like, PAN Zongfu, FANG Luo, HUANG Ping.
Study on the differences gene between proximal and distal colon cancer based on GEO database by bioinformatics
[J]. Chinese Journal of Clinical Pharmacology and Therapeutics, 2018, 23(4): 422-427.
|
[5] |
WANG Shiqi, HU Huawen, CHEN Xiaomin, WANG Jian, YE Honghua.
Effects of different intensities of warfarin on patients with coronary atherosclerotic heart disease complicated with atrial fibrillation: a comparative study
[J]. Chinese Journal of Clinical Pharmacology and Therapeutics, 2017, 22(12): 1410-1414.
|
[6] |
WU Ji-chu, LUO Can-xiang, OU YANG Ze-wei.
Amiodarone and losartan on recurrence and atrial structure for chronic atrial fibrillation after RFCA
[J]. Chinese Journal of Clinical Pharmacology and Therapeutics, 2015, 20(3): 318-322.
|
[7] |
WANG Jin-ping, LI Wen, CHEN Jia-yi, LI Lu.
Effect of xuebijing injection on liver gene expression of NF-κB in septic rats
[J]. Chinese Journal of Clinical Pharmacology and Therapeutics, 2014, 19(4): 385-388.
|
[8] |
CHENG Yuan-guang, WU Pei.
Expression of somatostatin receptor type 2 in colorectal cancer
[J]. Chinese Journal of Clinical Pharmacology and Therapeutics, 2013, 18(10): 1100-1104.
|
[9] |
SUN Hong, WANG Shao-ming, ZHUANG Jie, HUANG Xu-hui, YAO Jin-zhou.
Inhibiting URAT1 gene expression and reducing blood uric acid level of Chinese Traditional Medicine such as smilax glabra
[J]. Chinese Journal of Clinical Pharmacology and Therapeutics, 2012, 17(4): 403-407.
|
[10] |
WEI Meng, TAO Yi-fu, YE Fei, XIE Du-jiang, ZHU Jun-rong, YU Feng.
Investigation and analysis on initial warfarin dosage and hemorrhagic risk factors for atrial fibrillation
[J]. Chinese Journal of Clinical Pharmacology and Therapeutics, 2012, 17(1): 83-87.
|
[11] |
SHI Liang-hui, ZHANG Cai-quan, PENG Xiao-zhuang.
Relationship between the expression of LAT1,CD98hc and clinical pathological characteristics of gastric carcinoma
[J]. Chinese Journal of Clinical Pharmacology and Therapeutics, 2011, 16(12): 1361-1366.
|
[12] |
TANG Yi-qun, SUN Shu-juan, YIN Yue-miao, WANG Min-hui, HUANG Lu, SHAN Jiao-jiao.
Characteristics of atrial electrical remodeling in rats induced by paroxysmal atrial fibrillation
[J]. Chinese Journal of Clinical Pharmacology and Therapeutics, 2011, 16(11): 1205-1209.
|
[13] |
WANG Hua-jie, ZHANG Guo-hua, ZHOU-Zhen, FAN Xiu-zhen.
Effects of SiMiaoSanJiaWeiFang on the expression of human UAT and URAT1 transporter genes in HK-2 cells
[J]. Chinese Journal of Clinical Pharmacology and Therapeutics, 2010, 15(9): 972-977.
|
[14] |
WANG Gui-ping, YE Yun, YANG Xiao-qing, CHEN Xin-mei, LIA NG Shuang, ZHENG Wen-ling, MA Wen-li.
Gene expression profiles-based approach identifies candidate therapeutic compounds for lung adenocarcinoma
[J]. Chinese Journal of Clinical Pharmacology and Therapeutics, 2010, 15(3): 266-271.
|
[15] |
HUANG Lai-quan, WEI Zhong-lin, ZHANG Jun, ZHANG Dai-yun, WANG Xing-hong.
Expressions of BAG-1 and NF-κB P65 in the mononuclearcell of multiplemyeloma patients
[J]. Chinese Journal of Clinical Pharmacology and Therapeutics, 2010, 15(3): 292-297.
|